Impax Asset Management Group »

Edwards Lifesciences shares owned by Impax Asset Management Group

Quarter-by-quarter ownership of Edwards Lifesciences (EW) shares owned by Impax Asset Management Group from 13F filings

Historical chart of Impax Asset Management Group investment in Edwards Lifesciences

Tip: Access up to 7 years of quarterly data

All positions including Edwards Lifesciences held by Impax Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edwards Lifesciences by Impax Asset Management Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $856k 13k 65.99
2024-06-30 $721k 7.8k 92.37
2024-03-31 $745k 7.8k 95.56
2023-12-31 $595k 7.8k 76.25

More positions owned by Impax Asset Management Group

Microsoft Corp Common Stock (MSFT)
Linde Common Stock (LIN)
American Water Works Common Stock (AWK)
Pentair Common Stock (PNR)
NVIDIA Corp Common Stock (NVDA)
TE Connectivity Common Stock
Applied Materials Common Stock (AMAT)
Hubbell Common Stock (HUBB)
Mastercard Common Stock (MA)
Cintas Corp Common Stock (CTAS)
RenaissanceRe Holdings Common Stock (RNR)
Boston Scientific Corp Common Stock (BSX)
Veralto Corp Common Stock (VLTO)
Thermo Fisher Scientific Common Stock (TMO)
Aptiv Common Stock (APTV)

View all positions for Impax Asset Management Group

Top funds holding Edwards Lifesciences

BlackRock
Vanguard Group
BlackRock
State Street Corporation
Alliancebernstein
Bank of New York Mellon
Brown Advisory Holdings Incorporated
Geode Capital Management
Fisher Investments
Jpmorgan Chase & Co
Investec Asset Management
Morgan Stanley
Deutsche Bank Aktiengesellschaft
Henderson Group
Northern Trust

View all funds holding Edwards Lifesciences